课题基金 / 基金详情

项目摘要

项目成果

MICHAEL M LEDERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Case Western Reserve University AIDS Clinical Trials Unit serves a 5.4 million population region that accounts for 47% of Ohio's AIDS cases. This section provides rationale for the continuation of an established ACTU that is a vital community resource and is an important contributor to the national ACTG effort. This Cleveland and Toledo-based ACTU has a strong record of cost efficient accrual of patients including underserved minorities into ACTG trials. To provide additional trials access to minority populations, a second ACTU subunit will be established at MetroHealth Medical Center, a county hospital on Cleveland's West Side that serves large African-American and Hispanic communities. The main ACTU and its two subunits are the three largest HIV care providers in Northern Ohio and each provides care without regard to ability to pay. As both HIV care providers and AIDS researchers, these units integrate clinical care and clinical research and their staff have earned the trust and confidence of their patients and communities. Outreach to populations currently under-represented in ACTG trials is a major component of ACTU activities. These Units project a minimum accrual of 140 patients per year to ACTG trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHARMACOLOGY AGENDA
  • 批准号:
    5205123
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    MICHAEL M LEDERMAN
  • 依托单位:
    --
CORE--ADVANCED TECHNOLOGY LABORATORIES
  • 批准号:
    5205127
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    MICHAEL M LEDERMAN
  • 依托单位:
    --
ADULT AIDS CLINICAL RESEARCH
  • 批准号:
    3727024
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    MICHAEL M LEDERMAN
  • 依托单位:
RIFAMPIN, CIPROFLAXACIN, CLOFAZIMINE, ETHAMBUTOL, & AMIKACIN IN HIV+ INDIVIDUALS
海外基金